(Q38275100)

1 September 2017

1 reference

title

Behçet syndrome: from pathogenesis to novel therapies (English)

1 reference

1 September 2017

0 references

0 references

Gianluigi Mazzoccoli

1

0 references

author name string

Angela Matarangolo

2

1 reference

1 September 2017

Rosa Rubino

3

1 reference

1 September 2017

Michele Inglese

4

1 reference

1 September 2017

Angelo De Cata

5

1 reference

1 September 2017

2 December 2014

1 reference

Clinical and Experimental Medicine

1 September 2017

1 reference

1 September 2017

16

1 reference

1 September 2017

1

1 reference

1 September 2017

1-12

1 reference

https://scigraph.springernature.com/pub.10.1007/s10238-014-0328-z

1 September 2017

0 references

cites work

Criteria for Behçet's disease with reflections on all disease criteria

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Differential diagnosis and management of Behçet syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Clinical features of Behcet's disease in patients without oral aphthosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Validation of the International Study Group criteria for Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Epidemiology and clinical characteristics of Behçet's disease in the US: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Close association of HLA-B51 and B52 in Israeli patients with Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Association of Major Histocompatibility Complex Class I Chain-Related Gene A and HLA-B Alleles with Behçet's Disease in Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Frequency of HLA in patients with Behçet's disease and association with occlusive retinal vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

HLA-B phenotype modifies the course of Behçet's disease in Moroccan patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Familial aggregation in Behçet's disease: high frequency in siblings and parents of pediatric probands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Antibody response to oral streptococci in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Chemiluminescence of neutrophils from patients with Behçet's disease and its correlation with an increased proportion of uncommon serotypes of Streptococcus sanguis in the oral flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Fine antigen specificity of human gamma delta T cell lines (V gamma 9+) established by repetitive stimulation with a serotype (KTH-1) of a gram-positive bacterium, Streptococcus sanguis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Behçet's disease and antibody titers to various heat-shock protein 60s.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Increased seropositivity of Helicobacter pylori cytotoxin-associated gene-A in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Current concepts in the etiology and treatment of Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Detection of parvovirus B19 DNA in the lesional skin of patients with Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

The role of TLR2 and 4 in Behçet's disease pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Higher expression of Toll-like receptors 2, 3, 4, and 8 in ocular Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

IL-1β triggered by peptidoglycan and lipopolysaccharide through TLR2/4 and ROS-NLRP3 inflammasome-dependent pathways is involved in ocular Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Serum and erythrocyte adenosine deaminase activities in patients with Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Behcet's disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Skewed Th1 responses caused by excessive expression of Txk, a member of the Tec family of tyrosine kinases, in patients with Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Serum interleukin-18 levels in patients with Behçet's disease. Is its expression associated with disease activity or clinical presentations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

The demonstration of serum interleukin 6-8, tumor necrosis factor-alpha, complement, and immunoglobulin levels in Behçet's disease with ocular involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

CTLA4 gene polymorphisms and soluble CTLA4 protein in Behcet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

CTLA-4 +49A/G polymorphism is associated with Behçet's disease in a Tunisian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Alpha tropomyosin as a self-antigen in patients with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Identification of alpha-tropomyosin as a target self-antigen in Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

The pathophysiological significance of red blood cell nitric oxide concentrations in inflammatory Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

VEGF and mRNA VEGF expression in CSF from Behçet's disease with neurological involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Circulated activated platelets and increased platelet reactivity in patients with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of sweet syndrome and patients with active behcet disease: implication in neutrophil apoptosis dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Clinical Features of Patients with Behçet's Disease and Epididymitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Papulopustular skin lesions are seen more frequently in patients with Behçet's syndrome who have arthritis: a controlled and masked study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

The pustular skin lesions in Behcet's syndrome are not sterile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Neutrophilic vascular reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

The incidence and pathology of conjunctival ulceration in Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Conjunctival ulcers in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Pulmonary artery involvement and associated lung disease in Behçet disease: a series of 47 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Pulmonary vasculitis in behcet disease: a cumulative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Behçet syndrome manifestations and activity in the United States versus Turkey -- a cross-sectional cohort comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Renal Behçet's disease: a cumulative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Endomyocardial fibrosis in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Spectrum of cardiac lesions in Behçet disease: a series of 52 patients and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

A double-blind trial of depot corticosteroids in Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

A double-blind trial of colchicine in Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Treatment of Behçet's disease--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

A controlled trial of azathioprine in Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Azathioprine in severe uveitis of Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Low dose cyclosporin A versus pulsed cyclophosphamide in Behçet's syndrome: a single masked trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Novel approaches to Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

New approaches in the treatment of Adamantiades-Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Clinical experience with adalimumab in the treatment of ocular Behçet disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Interferon-alpha 2a treatment of neuro-Behcet disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Ocular involvement in Behçet's disease: first 5-year-results for visual development after treatment with interferon alfa-2a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Interferon-alpha--a new therapeutic option in refractory juvenile Behçet's disease with CNS involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

The use of interferon alpha in Behçet disease: review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Mycophenolate mofetil is ineffective in the treatment of mucocutaneous Adamantiades-Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Intravenous immunoglobulin therapy for resistant ocular Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Intravenous immunoglobulin in eye involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Cerebral venous thrombosis in Behçet's disease: clinical study and long-term follow-up of 25 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Behçet's disease and the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Neuropsychological follow-up of 12 patients with neuro-Behçet disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Neuro-Behçet's disease: epidemiology, clinical characteristics, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

The spectrum of nervous system involvement in Behçet's syndrome and its differential diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

21 January 2018

Neuro-Behçet syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Peripheral nervous system involvement in Behçet's disease. Case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Neurological manifestations of Behçet's disease in a Caribbean population: clinical and imaging findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Necrotising myositis in Behçet's disease: characteristic features on magnetic resonance imaging and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Peripheral nervous system involvement in patients with Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Behçet's syndrome and the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Cerebral venous thrombosis in Behçet's disease compared to those associated with other etiologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Neurologic manifestations of Behcet's disease: analysis of a series of 27 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Cerebral vasculitis and ischaemic stroke in Behçet's disease: report of one case and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

An unusual case of Behçet's disease presenting with bilateral internal carotid artery occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Endovascular treatment of Behçet's disease-associated intracranial aneurysms: report of two cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Histopathology of central nervous system lesions in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Autopsy case of neuro-Behçet's disease with multifocal neutrophilic perivascular inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Purkinje neuron physiology is altered by the inflammatory factor interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Behçet's disease: diagnostic and prognostic aspects of neurological involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Central nervous system symptoms in patients with Behçet disease receiving cyclosporine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Behçet disease presenting with neurological complications immediately after conversion from conventional cyclosporin A to microemulsion formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medications--results of a retrospective analysis of 117 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Efficacy of TNF {alpha} blockade in cyclophosphamide resistant neuro-Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Successful treatment of refractory neuro-Behcet's disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Effect of infliximab in progressive neuro-Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Analysis of CD28 and CTLA-4 gene polymorphisms in Turkish patients with Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Mapping the HLA association in Behçet's disease: A role for tumor necrosis factor polymorphisms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Cerebral venous thrombosis in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0328-Z

Low dose cyclosporin-A therapy in Behçet's disease

21 January 2018

1 reference

12 December 2020

Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease

1 reference

12 December 2020

Recurrent epididymo-orchitis in patients with Behçet's disease

1 reference

12 December 2020

Basilar artery aneurysm associated with Behçet's Disease: a case report.

1 reference

12 December 2020

Cardiovascular involvement in Behçet's disease

1 reference

12 December 2020

Neuro-Behçet's disease.

1 reference

12 December 2020

Evidence for linkage of the HLA-B locus in Behçet's disease, obtained using the transmission disequilibrium test

1 reference

12 December 2020

Aqueous humor nitric oxide levels in patients with Behçet disease

1 reference

12 December 2020

Onset signs, clinical course, prognosis, treatment and outcome of adult patients with Adamantiades-Behçet's disease in Greece.

1 reference

12 December 2020

Role of gammadelta T lymphocytes in the development of Behçet's disease

1 reference

12 December 2020

Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.

1 reference

12 December 2020

Efficacy of infliximab in intestinal Behçet's disease: a Korean multicenter retrospective study

1 reference

12 December 2020

Results of interferon alpha-2a therapy in patients with Behcet's disease

1 reference

12 December 2020

Enhanced interleukin 8 secretion in circulation of patients with Behçet's disease

1 reference

12 December 2020

Enhancement of endothelial cell E-selectin expression by sera from patients with active Behçet's disease: moderate correlation with anti-endothelial cell antibodies and serum myeloperoxidase levels

1 reference

12 December 2020

Cerebrospinal fluid interleukin-6 in progressive Neuro-Behçet's syndrome

1 reference

12 December 2020

Systemic interferon alpha 2b treatment in Behçet's syndrome.

1 reference

12 December 2020

Association of salivary S. mutans colonisation and mannose-binding lectin deficiency with gender in Behçet's disease.

1 reference

12 December 2020

Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis?

1 reference

12 December 2020

Adamantiades-Behçet's disease: serum IL-8 is a more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate

1 reference

12 December 2020

Familial Behçet's disease

1 reference

12 December 2020

Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12

1 reference

12 December 2020

Treatment of Adamantiades-Behçet disease with systemic interferon alfa

1 reference

12 December 2020

1 reference

12 December 2020

Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity

1 reference

12 December 2020

Antibodies to endothelial cells in patients with Behçet's disease

1 reference

12 December 2020

Interferon therapy for Behçet's disease

1 reference

12 December 2020

1 reference

12 December 2020

Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern

1 reference

12 December 2020

Cytokine profile in Behçet's disease patients. Relationship with disease activity

1 reference

12 December 2020

Increased peripheral blood gamma delta+ T cells and natural killer cells in Behçet's disease

1 reference

12 December 2020

Arthropathy in Behçet's disease

1 reference

12 December 2020

Haemostatic markers of procoagulant imbalance in Behçet's disease

1 reference

12 December 2020

Is the long-term use of systemic corticosteroids beneficial in the management of Behçet's syndrome?

1 reference

12 December 2020

Association of MICA alleles and HLA-B51 in Italian patients with Behçet's disease.

1 reference

12 December 2020

Treatment of Behcet's syndrome

1 reference

12 December 2020

The efficacy of cyclosporin-a in the treatment of Behçet's disease.

1 reference

12 December 2020

Circulating antibodies to inducible heat shock protein 70 in patients with uveitis

1 reference

12 December 2020

Evaluation of conventional therapy versus cyclosporine A in Behçet's syndrome

1 reference

12 December 2020

Interferon alpha for ocular Behçet's disease

1 reference

12 December 2020

Serum mannose-binding lectin levels are decreased in behcet's disease and associated with disease severity

1 reference

12 December 2020

Low dose MTX for progressive neuro-Behçet's disease. A follow-up study for 4 years

1 reference

12 December 2020

Streptococcal-related antigens stimulate production of IL6 and interferon-gamma by T cells from patients with Behcet's disease

1 reference

12 December 2020

A double blind study of colchicine in Behçet's disease

1 reference

12 December 2020

Immunopathogenesis of Behçet's disease.

1 reference

12 December 2020

Vascular involvement in Behçet's disease

1 reference

12 December 2020

Oligoclonal B lymphocyte expansion in the synovium of a patient with Behçet's disease

1 reference

12 December 2020

Differential expression of toll-like receptor 6 on granulocytes and monocytes implicates the role of microorganisms in Behcet's disease etiopathogenesis

1 reference

12 December 2020

Th17 cells in Behçet's disease: a new immunoregulatory axis.

1 reference

12 December 2020

Successful treatment of long-standing neuro-Behçet's disease with infliximab

1 reference

12 December 2020

Inflammatory mediators and posterior segment involvement in ocular Behcet disease.

1 reference

12 December 2020

Increased nitric oxide production in patients with Behçet's disease: is it a new activity marker?

1 reference

12 December 2020

Headache in Behçet's syndrome

1 reference

12 December 2020

Long-term effects of cyclophosphamide and colchicine treatment in Behçet's disease

1 reference

12 December 2020

Neurological complications in Behçet's syndrome

1 reference

12 December 2020

Interferon-alpha treatment of Behçet's disease

1 reference

12 December 2020

Behçet's syndrome patients have high levels of functional disability, fatigue and pain as measured by a Multi-dimensional Health Assessment Questionnaire (MDHAQ).

1 reference

12 December 2020

CNS involvement in neuro-Behçet syndrome: an MR study.

1 reference

12 December 2020

Recognition of B-cell epitopes of the 65 kDa HSP in Behçet's disease

1 reference

12 December 2020

Elevated levels of MMP-9 and TIMP-1 in the cerebrospinal fluid of neuro-Behçet's disease

1 reference

12 December 2020

Cytokine-induced programmed death of cultured sympathetic neurons

1 reference

12 December 2020

[The changes of Th lymphocyte subsets in patients with Behcet disease]

1 reference

12 December 2020

Comparative analysis of the association of HLA-B*51 suballeles with Behcet's disease in patients of German and Turkish origin

1 reference

12 December 2020

Phenotypic characteristics of B cells in Behçet's disease: increased activity in B cell subsets

1 reference

12 December 2020

Cerebrospinal fluid beta(2)-microglobulin in neuro-Behçet's syndrome

1 reference

12 December 2020

Mycophenolate mofetil as a novel immunosuppressant in the treatment of neuro-Behçet's disease with parenchymal involvement: presentation of four cases

1 reference

12 December 2020

Thrombosis and Behçet's syndrome in non-endemic regions

1 reference

12 December 2020

Budd-Chiari syndrome: a common complication of Behçet's disease

1 reference

12 December 2020

Abnormal QT dispersion in Behçet's disease

1 reference

12 December 2020

Intercellular adhesion molecule-1 gene polymorphisms in Behçet's Disease

1 reference

12 December 2020

Spontaneous dissection of the extracranial vertebral artery with spinal subarachnoid haemorrhage in a patient with Behçet's disease

1 reference

12 December 2020

Target organ associations in Turkish patients with Behçet's disease: a cross sectional study by exploratory factor analysis

1 reference

12 December 2020

Interleukin 8 in Behçet's disease

1 reference

12 December 2020

Soluble tumour necrosis factor receptors sTNFR1 and sTNFR2 are produced at sites of inflammation and are markers of arthritis activity in Behçet's disease

1 reference

12 December 2020

Interleukin-6 in neuro-Behçet's disease: association with disease subsets and long-term outcome

1 reference

12 December 2020

Fibrinolytic activity and d-dimer levels in Behçet's syndrome

1 reference

12 December 2020

Lack of association of HLA-B*51 with a severe disease course in Behçet's disease

1 reference

12 December 2020

Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behçet's disease

1 reference

12 December 2020

Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet's disease

1 reference

12 December 2020

Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet's disease: a pilot study

1 reference

12 December 2020

10.1007/S10238-014-0328-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

1 September 2017

0 references

1 reference